HSBC DIS.CERT. 07/24 BAS/ DE000HS01AL7 /
| 10/06/2024 21:35:09 | Var.0.000 | Denaro21:59:52 | Lettera21:59:52 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
|---|---|---|---|---|---|---|---|
| 21.890EUR | 0.00% | 21.850 Quantità in denaro: 2,000 |
21.950 Quantità in lettera: 2,000 |
BASF SE NA O.N. | - - | 26/07/2024 | Call |
GlobeNewswire
00:15
Centurion Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
GlobeNewswire
00:13
ROSEN, SKILLED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before...
GlobeNewswire
00:00
GICAI launches revolutionary global digital currency quantitative trading platform to improve invest...
GlobeNewswire
10/06
Empower Healthcare Solutions and DispatchHealth® collaborate to bring in-home urgent medical care to...
GlobeNewswire
10/06
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primar...
GlobeNewswire
10/06
Atour Lifestyle Holdings Limited Announces Proposed Registered Secondary Offering of American Deposi...
GlobeNewswire
10/06
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Hertz Global Holdings, Inc. Investors to Secure Counsel B...
GlobeNewswire
10/06
LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire
10/06
Bitfarms Announces Toronto Stock Exchange Deferral of Consideration of Shareholder Rights Plan
GlobeNewswire
10/06
Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to...
GlobeNewswire
10/06
Inception Growth Acquisition Limited Announces Extension of Business Combination Period and Addition...
GlobeNewswire
10/06
CANON UNVEILS THE FUTURE OF EVERYDAY VR CONTENT CREATION WITH NEW DUAL FISHEYE LENS
GlobeNewswire
10/06
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primar...
